Fundraising Fox

AI Proteins

Andover, US · Founded 2021 · Delaware corporation · 3 known investors

aiproteins.bio ↗

AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.

AI & Machine LearningBiotechDeep Techin /aiproteins@AI_Proteins

Founders & leadership

DV
Dominique VerhelleDirector
BM
Bill McKeeDirector
JN
Julia NovinaExecutive Officer
MA
Marc A. CohenExecutive Officer, Director
GM
Geoff MeyersonDirector
EP
Elena ProkupetsDirector
CN
Carl NovinaDirector
DD
Drew DennisonDirector
NB
Namandje BumpusDirector
AB
Arthur BeckerDirector
CB
Chris BahlExecutive Officer, Director
MS
Malcolm SalterDirector

Investors · 3

Mission BiocapitalSan Francisco · $500K
Tachyon VenturesLos Angeles
Cobro VenturesreportedMcleanvia Todd Kaloudis · board

Reported raises · per SEC filings

Form D private placements
▶$5MraisedApr 2024 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bobby SandageDirector
  • Julia A. NovinaExecutive Officer
  • Chris BahlExecutive Officer, Director
  • Bruce EvansDirector
  • Drew DennisonDirector
  • Wendy DwyerExecutive Officer
  • Todd KaloudisDirector
  • Noah BeermanExecutive Officer, Director
  • Malcolm SalterDirector
Offering amount
$10M
Amount sold
$5M
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.3MraisedAug 2023 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Noah BeermanExecutive Officer
  • Mark AllesDirector
  • Malcolm SalterDirector
  • Todd KaloudisDirector
  • Bobby SandageDirector
  • Chris BahlExecutive Officer, Director
  • Julia A. NovinaExecutive Officer
  • Drew DennisonDirector
  • Bruce EvansDirector
Offering amount
$10M
Amount sold
$8.3M
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.3MraisedJan 2022 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dominique VerhelleDirector
  • Bill McKeeDirector
  • Julia NovinaExecutive Officer
  • Marc A. CohenExecutive Officer, Director
  • Geoff MeyersonDirector
  • Elena ProkupetsDirector
  • Carl NovinaDirector
  • Drew DennisonDirector
  • Namandje BumpusDirector
  • Arthur BeckerDirector
  • Chris BahlExecutive Officer, Director
  • Malcolm SalterDirector
Offering amount
$18.2M
Amount sold
$11.3M
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news